Gade Terence P F, Buchanan Ian M, Motley Matthew W, Mazaheri Yousef, Spees William M, Koutcher Jason A
Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Clin Cancer Res. 2009 Jan 1;15(1):247-55. doi: 10.1158/1078-0432.CCR-08-0611.
Low-molecular weight (LMW) chemotherapeutics are believed to reach tumors through diffusion across capillary beds as well as membrane transporters. Unexpectedly, the delivery of these agents seems to be augmented by reductions in tumor interstitial fluid pressure, an effect typically associated with high-molecular weight molecules that reach tumors principally through convection. We investigated the hypothesis that improved intratumoral convection can alter tumor metabolism and enhance the delivery of a LMW chemotherapeutic agent to solid tumors.
For this purpose, we applied 31P/19F magnetic resonance spectroscopy (MRS) and magnetic resonance spectroscopic imaging (MRSI) to examine the influence of type I collagenase on tumor bioenergetics and the delivery of 5-fluorouracil (5FU) to HT29 human colorectal tumors grown s.c. in mice.
Collagenase effected a 34% reduction in tumor interstitial fluid pressure with an attendant disintegration of intratumoral collagen. Neither mice-administered collagenase nor controls receiving PBS showed changes in (31)phosphorus MRS-measured tumor bioenergetics; however, a time-dependent increase in the content of extracellular inorganic phosphate (Pi(e)) was observed in tumors of collagenase-treated animals. (31)Phosphorus MRSI showed that this increase underscored a more homogeneous distribution of Pi(e) in tumors of experimental mice. (19)Fluorine MRS showed that these changes were associated with a 50% increase in 5FU uptake in tumors of experimental versus control animals; however, this increase resulted in an increase in 5FU catabolites rather than fluoronucleotide intermediates that are required for subsequent cytotoxicity.
These data indicate that the modulation of convective flow within tumors can improve the delivery of (LMW) chemotherapeutics and show the potential role for noninvasive imaging of this process in vivo.
低分子量(LMW)化疗药物被认为是通过扩散穿过毛细血管床以及膜转运蛋白到达肿瘤部位。出乎意料的是,肿瘤间质液压力的降低似乎会增强这些药物的递送,这种效应通常与主要通过对流到达肿瘤的高分子量分子相关。我们研究了以下假设:改善肿瘤内对流可改变肿瘤代谢并增强低分子量化疗药物向实体瘤的递送。
为此,我们应用31P/19F磁共振波谱(MRS)和磁共振波谱成像(MRSI)来研究I型胶原酶对肿瘤生物能量学的影响以及5-氟尿嘧啶(5FU)向在小鼠皮下生长的HT29人结肠直肠癌肿瘤的递送。
胶原酶使肿瘤间质液压力降低了34%,同时肿瘤内胶原解体。给予胶原酶的小鼠和接受PBS的对照组在通过31磷MRS测量的肿瘤生物能量学方面均未显示出变化;然而,在胶原酶处理动物的肿瘤中观察到细胞外无机磷酸盐(Pi(e))含量随时间增加。31磷MRSI显示,这种增加突出了实验小鼠肿瘤中Pi(e)分布更均匀。19氟MRS显示,这些变化与实验动物肿瘤中5FU摄取增加50%相关;然而,这种增加导致5FU分解代谢物增加,而不是后续细胞毒性所需的氟核苷酸中间体增加。
这些数据表明,调节肿瘤内的对流可改善低分子量化疗药物的递送,并显示了该过程在体内无创成像的潜在作用。